Print pageEmail pageRSS Feeds

We are building a strong, well-run business, structured to deliver sustainable results over the long term.

Along with biotechnology leadership, the ARIAD team is focused on its commitment to deliver long-term value to investors through solid business execution. That means maintaining disciplined cost control, thoughtful capital deployment and the highest standards of corporate governance.

Webcast ImageWebcast - Replay
ARIAD Pharmaceuticals, Inc. Annual Shareholder Meeting
06/25/14 at 10:00 a.m. ET
ARIAD Pharmaceuticals, Inc. Annual Shareholder Meeting
Wednesday, June 25, 2014 10:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Recent Press Releases
More >>
06/23/14
ARIAD Announces Three Key Appointments to Its Global Management Team
06/12/14
ARIAD Announces Pricing of $200 Million Offering of 3.625% Convertible Senior Notes Due 2019
Investor Downloads

Download Documentation Corporate Presentation
There are currently no items available.
There are currently no items available.
More >>

ARIAD Stock Price: $6.09

Stock Symbol: ARIA

Stock Exchange: NASDAQ

Stock Quote at: 07/11/14

4:00 p.m. ET
(US Dollar)
CHANGE (%) Stock is Up 0.14 (2.35%)
VOL5,366,200
OPEN$5.93
PREV. CLOSE$5.95
DAY HIGH$6.17
DAY LOW$5.85
52 WK. HIGH$23.00
Minimum 20 minute delay
Refresh quote
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

You are now leaving this website. If you would like to continue, click Continue.
CancelContinue